Our projects

Automating parasite egg detectionThe DIDIDI project is developing automated systems and AI tools to provide a more rapid assessment of parasitic worm burdens.

Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...

Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...

Factors affecting susceptibility to and severity of mpoxThe DECIPHER-MPOX project is identifying host- and virus-related factors responsible for susceptibility to and the severity of mpox...

Accelerating recovery from choleraThe HUNADIA project is assessing whether a newly developed drug can alleviate the symptoms of cholera, speeding up recovery and shortening or potentially...

Detecting tuberculosis in stool samplesThe STOOL4TB project has been awarded Global Health EDCTP3 funding to complete its EDCTP2-funded study of TB detection in children and people living...

Integrated control of multiple parasitic worm infectionsThe 3SI-CONTROL project is assessing whether it is safe and effective to administer multiple antiparasitic drugs simultaneously and...

Improving treatment of TB meningitisWith Global Health EDCTP3 funding, the EDCTP2-funded INTENSE-TBM project is completing a trial that could radically improve the treatment of tuberculosis...

A platform for evaluating Lassa fever treatmentsThe INTEGRATE project is creating a clinical trial platform able to support efficacy studies on multiple Lassa fever therapeutics.

Enhancing genomic surveillance in the Great Lakes regionThe GREAT-LIFE project is building a genomics-based infrastructure to track existing and new infectious disease threats and...

Extending malaria treatment options for young childrenThe ASAQ-PAC project is developing a child-friendly version of a key antimalarial combination to enable malaria control programmes to...

Protecting the potency of a key tuberculosis drugThe TASP project is evaluating new approaches to extend the lifespan of the critical tuberculosis drug, bedaquiline, by improving detection...

Progressing a multifunctional antimalarialThe RAMP project is advancing the development of a novel antimalarial drug with the potential to both treat the disease and block the transmission...

Treating epilepsy caused by parasite infection  The NeuroSolve project is evaluating a new treatment for patients who develop epileptic seizures when tapeworm larvae become lodged in their...

Reaching those missing out on vaccinationThe REACH-OUT project is developing strategies to ensure that more ‘zero-dose’ children – those missing out entirely on the benefits of vaccines –...

Supporting mpox responses and research in eastern DRCThe MBOTE-SK project is embedding research within the response to the new clade Ib mpox outbreak in eastern DRC.

Enhancing leprosy controlThe EDCTP2-funded PEP4LEP project has received additional funding to complete its study of two possible models for the delivery of preventive leprosy treatments and...

Tracking mpox at the Congo–DRC borderThe MPOX-PROBE project is tracking the emergence and spread of mpox on the border between the Democratic Republic of the Congo (DRC) and the Republic of...

Capacity strengthening in West AfricaThe WANETAM-4 project is strengthening a key West African research network to support further capacity building, development of the next generation of...